Press releasePRNewswire
Haemonetics
HAE · NYSE
$118.21−$0.52 (−0.44%)TodayMarket closed ·
Prev close $118.73
Latest news
- Press releasePRNewswire
Haemonetics Announces FDA Approval of PerQseal® Elite Vascular Closure System
- NewsAkanksha Bakshi
Haemonetics Stock Hits 52-Week High - Here's Why
- NewsAvi Kapoor
Helen Of Troy Posts Upbeat Q2 Earnings, Joins Pacira Biosciences, Wolfspeed And Other Big Stocks Moving Higher On Thursday
- News
Haemonetics Q1 2027 Earnings Call Transcript
- Press releasePRNewswire
Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2027 Results: November 5, 2026
- Press releasePRNewswire
AZENTA ANNOUNCES LEADERSHIP TRANSITION
- NewsHenry Khederian
Haemonetics Shares Hit New 52-Week High: What's Happening?
- News
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- News
Haemonetics To Supply CSL Plasma With Its NexSys PCS Devices With Persona PLUS Technology And Allow Purchases Of Related Disposables In The U.S.; Agreement Is Non-Exclusive And With No Minimum Purchase Commitments
- Press releasePRNewswire
Haemonetics Corporation Announces First Quarter Fiscal 2027 Financial Results Available on Investor Relations Website
- Press releasePRNewswire
New Study Offers Additional Evidence for the VASCADE MVP® XL System's Effectiveness in Electrophysiology Procedures with Large Bore Sheaths
- Press releasePRNewswire
Martin Madaus Elected to Haemonetics Board of Directors
- Press releasePRNewswire
Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2027 Results: August 6, 2026
- Press releasePRNewswire
Haemonetics Updates Financial Reporting Segments
- Press releasePRNewswire
Haemonetics to Present at Goldman Sachs 47th Annual Global Healthcare Conference
- Press releasePRNewswire
Haemonetics Corporation Announces Fourth Quarter Fiscal 2026 Financial Results Available on Investor Relations Website
- Press releasePRNewswire
Haemonetics to Present at Bank of America 2026 Healthcare Conference
- Press releasePRNewswire
New Study Highlights Safety and Efficacy Profile of Haemonetics' VASCADE MVP® XL in Large-Bore Venous Access Closure Procedures
- Press releasePRNewswire
Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2026 Results: May 7, 2026
- Press releasePRNewswire
Haemonetics Receives FDA Approval for Expanded Labeling of the VASCADE MVP® XL Venous Vascular Closure System
- Press releasePRNewswire
Haemonetics Receives FDA Clearance for NexSys® PCS Plasma Collection System with Persona® PLUS Technology
- Press releasePRNewswire
Haemonetics to Present at Raymond James 47th Annual Institutional Investors Conference
- News
Earnings Scheduled For February 5, 2026
- Press releasePRNewswire
Haemonetics Corporation Announces Third Quarter Fiscal 2026 Financial Results Available on Investor Relations Website
- Press releaseGlobe Newswire
Orchestra BioMed to Receive Up to $21 Million in Proceeds from Acquisition of Vivasure by Haemonetics
- NewsAkanksha Bakshi
Haemonetics Expands Heart Surgery Arsenal With Vivasure Acquisition
- Press releaseBusiness Wire
Vivasure Medical Announces Acquisition by Haemonetics Corporation
- Press releasePRNewswire
Haemonetics Acquires Vivasure Medical Limited
- Press releasePRNewswire
Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2026 Results: February 5, 2026
- Press releasePRNewswire
Haemonetics to Present at 44th Annual J.P. Morgan Healthcare Conference
- NewsAvi Kapoor
Datadog, Fastly, Planet Fitness, Air Products And Other Big Stocks Moving Higher On Thursday
- News
12 Health Care Stocks Moving In Thursday's Intraday Session
- News
Earnings Scheduled For November 6, 2025
- Press releasePRNewswire
Haemonetics Corporation Announces Second Quarter Fiscal 2026 Financial Results Available on Investor Relations Website
- Press releaseBusiness Wire
Vivasure Medical Submits PMA Application for PerQseal® Elite and Secures Expanded Venous Indication in Europe
- News
Haemonetics Announces Executive Leadership Updates; Frank Chan Joins Haemonetics As Executive Vice President, Chief Operating Officer, Effective April 7, 2025
- Press releasePRNewswire
Haemonetics Announces Executive Leadership Updates
- Press releaseGlobe Newswire
Orchestra BioMed Reports Third Quarter 2024 Financial Results and Provides a Business Update
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.